Healthcare

The US pharmaceutical industry spends approximately $100 billion annually to develop new pharmaceutical drugs and medical devices. Today, a new drug takes approximately 15 years and over $1 billion to bring to market. Product development costs could be greatly reduced by using animal models that more closely resemble humans in their disease states ...

The relationships between imaging vendors and hopsital systems are evolving. From traditional one-time purchase and service contracts, vendors and hospital systems are currently entering into long-term strategic risk-sharing partnerships that enable care providers to optimize patient scanning experience, improve work flow efficiencies, reduce costs...

According to the National Institute of Health (NIH), there are more than 80 types of autoimmune diseases, of which less than 30 are diagnosable. Being 1 of the top 10 causes of death in the United States, there is a critical need in the market for the diagnosis and the treatment of both systemic diseases, such as lupus and rheumatoid arthritis, as ...

The total imaging market is growing steadily at the rate of approximately 8%, as value segment systems are increasingly finding their acceptance in the global markets. Growing awareness and end users’ attention to the detailed design of value segment systems for their requirements with optimized cost metrics in cash-trapped developed markets and...

\ Frost & Sullivan attended the annual meeting of the Radiological society of North America (RSNA). The four themes we have developed in our coverage of the 2015 edition fall under the topic areas of:\ I- Competitive Landscape and New Business Models, looking at new entrants in the capital imaging equipment arena, the recent developments in techn...